---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-080764"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:50:09.180586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics raises ~$187M net in public offering of 9.4M ADSs at $21.25/sh

## Summary
- Public offering of 9,411,766 ADSs (or non-voting ordinary shares) at $21.25 per share; net proceeds ~$187.3M.
- Underwriters granted 30-day option to purchase up to 1,411,764 additional ADSs.
- Preliminary cash and cash equivalents of ~$340.4M as of June 30, 2023 (unaudited).
- Offering expected to close July 17, 2023; 60-day lock-up for directors, officers and company.

## SEC filing metadata
- accession: 0001104659-23-080764
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/0001104659-23-080764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/tm2321220d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-080764
- JSON: https://secwatch.observer/filing/0001104659-23-080764.json
- Plain text: https://secwatch.observer/filing/0001104659-23-080764.txt

## Key facts
- Material Agreements
  BICYCLE THERAPEUTICS PLC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives) valued at approximately $187.3 million (effective 2023-07-12).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives)
  - Value: approximately $187.3 million
  - Effective: 2023-07-12
  source text: On July 12, 2023, Bicycle Therapeutics plc (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (the “ Representatives ”), as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), pursuant to which the Company agreed to issue and sell 9,411,766 American Depositary Shares (“ ADSs ”), each representing one of the Company’s ordinary shares, nominal value £0.01 per share, and, in lieu of ADSs to investors that so choose, non-voting ordinary shares, nominal value £0.01 per share (“ Non-Voting Ordinary Shares ”), each at a public offering price of $21.25 per share (the “ Offering ”). The net proceeds to the Company from the Offering are expected to be approximately $187.3 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/0001104659-23-080764-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.